| scholarly article | Q13442814 |
| P50 | author | Ju Hyun Shim | Q82226483 |
| P2093 | author name string | Sae Hwan Lee | |
| Jae Keun Lee | |||
| Young-Suk Lim | |||
| Young-Hwa Chung | |||
| Dong Jin Suh | |||
| Han Chu Lee | |||
| Yung Sang Lee | |||
| Kang Mo Kim | |||
| P2860 | cites work | Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies | Q29614505 |
| Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity | Q29614914 | ||
| Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients | Q33179022 | ||
| Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study | Q33709267 | ||
| Evaluation of abnormal liver-enzyme results in asymptomatic patients | Q33899029 | ||
| AGA technical review on the evaluation of liver chemistry tests | Q34152798 | ||
| Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level | Q34481474 | ||
| Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center | Q36776772 | ||
| A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update | Q37290723 | ||
| Alanine aminotransferase in clinical practice. A review | Q37636081 | ||
| Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. | Q42982768 | ||
| Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C. | Q42998370 | ||
| Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study | Q43269850 | ||
| Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease | Q43660617 | ||
| Updated definitions of healthy ranges for serum alanine aminotransferase levels | Q44047068 | ||
| The utility of radiological imaging in nonalcoholic fatty liver disease. | Q44116674 | ||
| Alanine aminotransferase elevation not associated with fatty liver is frequently seen in obese Japanese women | Q44119101 | ||
| New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects | Q44249557 | ||
| Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women | Q46613619 | ||
| Predicting cirrhosis risk based on the level of circulating hepatitis B viral load | Q46985831 | ||
| Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. | Q50889874 | ||
| [Management of Chronic Hepatitis B] | Q82829972 | ||
| Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD) | Q94608587 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | L-alanine | Q218642 |
| P304 | page(s) | 1577-1583 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology | |
| P478 | volume | 51 |
| Q28546931 | A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B |
| Q33853195 | A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels |
| Q34184642 | A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B. |
| Q30585177 | A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data |
| Q40416496 | ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries |
| Q100416053 | ALDH2 genotype modulates the association between alcohol consumption and AST/ALT ratio among middle-aged Japanese men: a genome-wide G × E interaction analysis |
| Q101461119 | ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation |
| Q38655638 | After successful hepatitis C virus antiviral therapy: It looks that normal alanine aminotransferase level is not the normal. |
| Q35159698 | Alanine aminotransferase and risk of the metabolic syndrome: a linear dose-response relationship |
| Q26828819 | Alanine aminotransferase-old biomarker and new concept: a review |
| Q27006557 | Antiviral therapy for chronic hepatitis B in China |
| Q42859204 | Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments. |
| Q38433002 | Association between serum calcium and phosphorus concentrations with non-alcoholic fatty liver disease in Korean population |
| Q36294375 | Association of reduced renal function with hepatitis B virus infection and elevated alanine aminotransferase |
| Q36262814 | Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention |
| Q51181013 | Biocatalytic analysis of biomarkers for forensic identification of gender. |
| Q46962933 | Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study |
| Q53287765 | Can "healthy" normal alanine aminotransferase levels identify the metabolically obese phenotype? Findings from the Korea national health and nutrition examination survey 2008-2010. |
| Q42955628 | Canadian patients with chronic hepatitis B cannot access appropriate drug treatments: a call for change |
| Q35215610 | Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program |
| Q99580855 | Clinical Difference between Acute Appendicitis and Acute Right-Sided Colonic Diverticulitis |
| Q34589232 | Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection |
| Q42198665 | Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels. |
| Q35122003 | Complex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies |
| Q34462246 | Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients |
| Q42198659 | Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B. |
| Q36770544 | Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels |
| Q37788776 | Endpoints of hepatitis B treatment |
| Q38622926 | Estimation of Upper Limit of Normal for Serum Alanine Transaminase in Healthy South Indian Population |
| Q42182711 | Estimation of normal values of serum transaminases based on liver histology in healthy Asian Indians |
| Q33648066 | Exploration of Biomarkers for Amoxicillin/Clavulanate-Induced Liver Injury: Multi-Omics Approaches |
| Q53631092 | Forensic determination of blood sample age using a bioaffinity-based assay. |
| Q43585965 | Healthy range for serum ALT and the clinical significance of "unhealthy" normal ALT levels in the Korean population |
| Q36515750 | Hepatic Enzyme's Reference Intervals and Their Modulating Factors in Western Indian Population |
| Q36241726 | Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels. |
| Q41240306 | Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load |
| Q35841903 | High Dietary Sodium Intake Assessed by Estimated 24-h Urinary Sodium Excretion Is Associated with NAFLD and Hepatic Fibrosis |
| Q34391308 | High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B. |
| Q35691243 | Immune tolerant hepatitis B: a clinical dilemma. |
| Q35783908 | Increased liver markers are associated with higher risk of type 2 diabetes |
| Q90228422 | Is There a Link between Basal Metabolic Rate, Spleen Volume and Hepatic Growth Factor Levels in Patients with Obesity-Related NAFLD? |
| Q64897844 | KASL clinical practice guidelines for management of chronic hepatitis B. |
| Q26752475 | KASL clinical practice guidelines: management of chronic hepatitis B |
| Q38192584 | Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. |
| Q42580880 | Liver function tests as indicators of metabolic syndrome |
| Q90080181 | Low Alanine Aminotransferase Cut-Off for Predicting Liver Outcomes; A Nationwide Population-Based Longitudinal Cohort Study |
| Q51179009 | Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study. |
| Q33599576 | Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients |
| Q38164074 | Non-alcoholic fatty liver disease: factors associated with its presence and onset |
| Q45989543 | Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels. |
| Q42434503 | Optimal cut-off value of alanine aminotransferase level to precisely estimate the presence of fatty liver in patients with poorly controlled type 2 diabetes |
| Q37381790 | Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B |
| Q38469602 | Prevalence of alcoholic liver disease among Korean adults: results from the fourth Korea National Health and Nutrition Examination Survey, 2009. |
| Q39051404 | Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis. |
| Q36348818 | Relationship between Serum Aminotransferase Levels and Metabolic Disorders in Northern China |
| Q86512409 | Revising the upper limit of normal for levels of serum alanine aminotransferase in a Middle Eastern population with normal liver histology |
| Q91728482 | Risk of metabolic syndrome in participants within the normal range of alanine aminotransferase: A population-based nationwide study |
| Q37634822 | SASLT practice guidelines for the management of hepatitis B virus. |
| Q87951149 | Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects |
| Q35036631 | Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALT |
| Q42875274 | The Author's Response: Anti-Viral Therapy for Compensated Liver Cirrhosis Patients with Normal Alanine Aminotransferase. |
| Q89523215 | Unresolved issues of immune tolerance in chronic hepatitis B |
| Q50190669 | Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance |
| Q41022606 | Upper Normal Alanine Aminotransferase Range and Insulin Resistance in Korean Adolescents: Korean National Health and Nutrition Examination Survey, 2009-2010. |
| Q35713666 | Upper limits of normal for alanine aminotransferase activity in the United States population |
| Q53390652 | Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease. |
| Q64913524 | Utility of ALT Concentration in Men and Women with Nonalcoholic Fatty Liver Disease: Cohort Study. |
| Q36008958 | Visceral adipose tissue area as an independent risk factor for elevated liver enzyme in nonalcoholic fatty liver disease. |
| Q58622652 | What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI) |
Search more.